Yale New Haven Hospital — New Haven, Connecticut

Public research footprint of Yale New Haven Hospital, compiled from the ClinicalTrials.gov public registry.

812

Registered studies

328

Active

158

Recruiting now

360

Completed

109

Stopped or withdrawn

Most-studied conditions

Anatomic Stage II Breast Cancer AJCC v8 · B Acute Lymphoblastic Leukemia · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT06407427 — Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation (Recruiting)
NCT04181060 — Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Yale New Haven Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.